James I. Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James I. Cohen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Peter E. Andersen
11 shared publicationsMark K. Wax
Department of Otolaryngology/Head and Neck Surgery, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd., PV-01, Portland, OR 97201
4 shared publications- Mark K. Wax
Department of Otolaryngology Oregon Health & Science University Portland Oregon USA
4 shared publications - Neil D. Gross
Department of Otolaryngology–Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon
3 shared publications Bronwyn E. Hamilton
2 shared publicationsEdwin Everts
2 shared publications
Latest Publications
- 1 January 2011
- Published by Elsevier
- p. 156-163
Defatting Tracheotomy
- 1 January 2011
- Published by Elsevier
- p. 133-142
Operations on the Cervical Esophagus and Cervical Spine
- 1 January 2011
- Published by Elsevier
- p. 133-142
Operations on the Cervical Esophagus and Cervical Spine
- 1 January 2011
- Published by Elsevier
Contributors
- Open Access
- 15 September 2008
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 134 (9) , 973-978
Utility of Computed Tomography in the Detection of Subclinical Nodal Disease in Papillary Thyroid Carcinoma
The role of lymph node dissection in the management of papillary thyroid carcinoma (PTC) remains controversial given the overall excellent long-term survival and lack of documented survival benefit with prophylactic lymphadenectomy. When one considers removal of subclinical (nonpalpable) metastases, particularly in the central compartment, questions arise concerning the ability of available imaging studies to localize disease adequately for a curative surgical intent. Although computed tomography (CT) is routinely used to guide surgical planning in head and neck squamous cell carcinoma (HNSCC), its utility in PTC is less established. This is reflected in the 2006 American Thyroid Association Guidelines Taskforce recommendation in favor of preoperative imaging with ultrasonography.1 The taskforce recommended not using preoperative imaging with CT, noting that its sensitivity in the setting of PTC remains unknown. Despite the lack of data regarding its efficacy, CT offers several potential advantages over ultrasonography. Computed tomography provides static anatomical information in a fully retrievable format. This facilitates subsequent intraoperative correlation with surgical landmarks. The acquisition of images is also less operator dependent compared with ultrasonography, promoting reproducibility. Computed tomography may excel in specific settings, such as patients with a thick neck or for visualization of the low paratracheal nodes, which may be obscured by the sternum or tracheal air shadow when ultrasonography is used. In addition, the anatomical levels that form the basis of the current surgical technique have been formalized using CT-based criteria,2 which promotes consistent communication between the radiologist and the surgeon in regard to disease location. Disadvantages of CT include increased cost and radiation exposure.
- 15 September 2008
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 134 (9) , 973-978
Open AccessUtility of Computed Tomography in the Detection of Subclinical Nodal Disease in Papillary Thyroid Carcinoma
The role of lymph node dissection in the management of papillary thyroid carcinoma (PTC) remains controversial given the overall excellent long-term survival and lack of documented survival benefit with prophylactic lymphadenectomy. When one considers removal of subclinical (nonpalpable) metastases, particularly in the central compartment, questions arise concerning the ability of available imaging studies to localize disease adequately for a curative surgical intent. Although computed tomography (CT) is routinely used to guide surgical planning in head and neck squamous cell carcinoma (HNSCC), its utility in PTC is less established. This is reflected in the 2006 American Thyroid Association Guidelines Taskforce recommendation in favor of preoperative imaging with ultrasonography.1 The taskforce recommended not using preoperative imaging with CT, noting that its sensitivity in the setting of PTC remains unknown. Despite the lack of data regarding its efficacy, CT offers several potential advantages over ultrasonography. Computed tomography provides static anatomical information in a fully retrievable format. This facilitates subsequent intraoperative correlation with surgical landmarks. The acquisition of images is also less operator dependent compared with ultrasonography, promoting reproducibility. Computed tomography may excel in specific settings, such as patients with a thick neck or for visualization of the low paratracheal nodes, which may be obscured by the sternum or tracheal air shadow when ultrasonography is used. In addition, the anatomical levels that form the basis of the current surgical technique have been formalized using CT-based criteria,2 which promotes consistent communication between the radiologist and the surgeon in regard to disease location. Disadvantages of CT include increased cost and radiation exposure.
- 1 August 2008
- Published by Elsevier in Oral and Maxillofacial Surgery Clinics of North America
- Vol. 20 (3) , 431-443
Thyroid Disorders: Evaluation and Management of Thyroid Nodules
- 1 August 2008
- Published by Elsevier in Oral and Maxillofacial Surgery Clinics of North America
- Vol. 20 (3) , 431-443
Thyroid Disorders: Evaluation and Management of Thyroid Nodules
- 1 August 2008
- Published by Wiley in The Laryngoscope
- Vol. 118 (8) , 1405-1410
The Role of Computed Tomography for Localization of Parathyroid Adenomas
Objective/Hypothesis: The purpose of this study was to evaluate the use of computed tomography (CT) for localization of parathyroid adenomas (PA) when first‐line imaging is indeterminate.Study Design: Retrospective case series.Methods: A search of operating room and radiology records identified 223 surgical explorations for primary hyperparathyroidism. Adenoma locations on CT, ultrasound, and nuclear scintigraphy were correlated with an independent review of operative records.Results: The presence of adenoma in the correct side and quadrant of the neck was predicted by CT in 89% and 77% of studies, respectively. When first‐line studies were indeterminate, the positive predictive value of CT for localization of PA to the correct side and quadrant of the neck was 87% and 69%, respectively.Conclusions: When first‐line localization studies are indeterminate in patients with primary hyperparathyroidism, CT is a valuable, rapid, and widely available imaging modality that can be used to localize PA.
- 1 August 2008
- Published by Wiley in The Laryngoscope
- Vol. 118 (8) , 1405-1410
The Role of Computed Tomography for Localization of Parathyroid Adenomas
Objective/Hypothesis: The purpose of this study was to evaluate the use of computed tomography (CT) for localization of parathyroid adenomas (PA) when first‐line imaging is indeterminate.Study Design: Retrospective case series.Methods: A search of operating room and radiology records identified 223 surgical explorations for primary hyperparathyroidism. Adenoma locations on CT, ultrasound, and nuclear scintigraphy were correlated with an independent review of operative records.Results: The presence of adenoma in the correct side and quadrant of the neck was predicted by CT in 89% and 77% of studies, respectively. When first‐line studies were indeterminate, the positive predictive value of CT for localization of PA to the correct side and quadrant of the neck was 87% and 69%, respectively.Conclusions: When first‐line localization studies are indeterminate in patients with primary hyperparathyroidism, CT is a valuable, rapid, and widely available imaging modality that can be used to localize PA.
- 1 May 2008
- Published by Wiley in The Laryngoscope
- Vol. 118 (5) , 768-775
Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer
Context: Although commonly performed, data are lacking regarding efficacy and safety of lymph node dissection (LND) for recurrent/persistent papillary thyroid cancer (PTC).Objective: Evaluate the efficacy and morbidity of LND in recurrent/persistent PTC.Design: Retrospective review of central or lateral LND performed for persistent/recurrent PTC between January 2004 and March 2006.Setting: Multidisciplinary thyroid cancer clinic with a single surgeon at an academic medical center.Participants: Seventy‐five patients who underwent 79 LND for persistent/residual PTC. Safety analysis included all 79 resections. Exclusion criteria for the efficacy analysis were factors prohibiting evaluation of thyroglobulin (Tg) response. Forty‐one resections were included in the efficacy analysis.Intervention: Selective LND per standard of care.Main Outcome Measure: Primary outcome was the Tg response to LND. Secondary outcomes were surgical complications.Results: Thirty‐nine of the 41 evaluable resections also had Tg data allowing classification of Tg response. Of 39 classifiable resections, 16 (41%) resulted in undetectable postoperative stimulated Tg levels. An additional 12 resections resulted in significant (≥50%) reductions in suppressed or stimulated Tg levels for an overall improvement rate of 72%. Of all 79 resections, 25 (32%) resulted in minor and 7 (9%) resulted in major complications.Conclusions: LND for persistent/recurrent PTC is a relatively safe procedure in experienced hands. It can lead to an undetectable Tg in 41% of cases and produce a major Tg reduction in an additional 31%. Its efficacy in short‐term follow‐up is comparable with that reported for I‐131, and it should be considered in the management of persistent/recurrent PTC.
- 1 May 2008
- Published by Wiley in The Laryngoscope
- Vol. 118 (5) , 768-775
Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer
Context: Although commonly performed, data are lacking regarding efficacy and safety of lymph node dissection (LND) for recurrent/persistent papillary thyroid cancer (PTC).Objective: Evaluate the efficacy and morbidity of LND in recurrent/persistent PTC.Design: Retrospective review of central or lateral LND performed for persistent/recurrent PTC between January 2004 and March 2006.Setting: Multidisciplinary thyroid cancer clinic with a single surgeon at an academic medical center.Participants: Seventy‐five patients who underwent 79 LND for persistent/residual PTC. Safety analysis included all 79 resections. Exclusion criteria for the efficacy analysis were factors prohibiting evaluation of thyroglobulin (Tg) response. Forty‐one resections were included in the efficacy analysis.Intervention: Selective LND per standard of care.Main Outcome Measure: Primary outcome was the Tg response to LND. Secondary outcomes were surgical complications.Results: Thirty‐nine of the 41 evaluable resections also had Tg data allowing classification of Tg response. Of 39 classifiable resections, 16 (41%) resulted in undetectable postoperative stimulated Tg levels. An additional 12 resections resulted in significant (≥50%) reductions in suppressed or stimulated Tg levels for an overall improvement rate of 72%. Of all 79 resections, 25 (32%) resulted in minor and 7 (9%) resulted in major complications.Conclusions: LND for persistent/recurrent PTC is a relatively safe procedure in experienced hands. It can lead to an undetectable Tg in 41% of cases and produce a major Tg reduction in an additional 31%. Its efficacy in short‐term follow‐up is comparable with that reported for I‐131, and it should be considered in the management of persistent/recurrent PTC.
- 29 April 2008
- Published by Wiley in Head & Neck
- Vol. 30 (9) , 1154-1155
Editorial comment